Veradermics, Incorporated (MANE)Healthcare | Biotechnology | New Haven, United States | NYSE
96.07 USD
+1.67
(1.769%)
⇧
(June 12, 2026, 4 p.m.
EDT)
After hours: 94.00 -2.07 (-2.070%) ⇩ (June 12, 2026, 6:58 p.m. EDT) |
Hot Take ↕ | June 7, 2026, 3:28 a.m. EDT
The immediate outlook is driven by a sharp technical rebound from the $32 lows, with the stock trading significantly above its 50-day and 200-day moving averages, suggesting strong recent momentum. However, this price action is entirely disconnected from the company's financial reality, which remains deeply distressed with negative earnings and negative operating cash flow. The lack of any dividend history confirms this is a pure speculative vehicle reliant on future clinical success rather than current cash generation. While the recent surge and analyst upgrades provide a short-term catalyst, the absence of a multi-year price history and the deteriorating fundamentals make this a high-risk, non-income investment suitable only for aggressive capital allocation. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.003 |
| Market Cap | 4,013,678,592 |
| Forward P/E | -31.62 |
| Website | https://www.veradermics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.5449007 |
| Address1 | 470 James Street |
| Address2 | Suite 2 |
| All Time High | 117.71 |
| All Time Low | 32.0 |
| Ask | 102.34 |
| Ask Size | 100 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 429,290 |
| Average Daily Volume3 Month | 581,185 |
| Average Volume | 581,185 |
| Average Volume10Days | 429,290 |
| Bid | 92.42 |
| Bid Size | 500 |
| Book Value | 10.462 |
| City | New Haven |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 96.07 |
| Current Ratio | 59.123 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,780,012,800 |
| Day High | 98.93 |
| Day Low | 92.11 |
| Debt To Equity | 0.003 |
| Earnings Timestamp | 1,778,589,000 |
| Earnings Timestamp End | 1,786,624,200 |
| Earnings Timestamp Start | 1,786,624,200 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 3,889,207,552 |
| Eps Current Year | -3.04965 |
| Eps Forward | -3.03799 |
| Eps Trailing Twelve Months | -2.64 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 91.1918 |
| Fifty Day Average Change | 4.8781967 |
| Fifty Day Average Change Percent | 0.053493805 |
| Fifty Two Week Change Percent | 154.49007 |
| Fifty Two Week High | 117.71 |
| Fifty Two Week High Change | -21.64 |
| Fifty Two Week High Change Percent | -0.18384165 |
| Fifty Two Week Low | 32.0 |
| Fifty Two Week Low Change | 64.07 |
| Fifty Two Week Low Change Percent | 2.0021875 |
| Fifty Two Week Range | 32.0 - 117.71 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,770,215,400,000 |
| Float Shares | 27,208,788 |
| Forward Eps | -3.03799 |
| Forward P E | -31.62288 |
| Full Exchange Name | NYSE |
| Full Time Employees | 24 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02737 |
| Held Percent Institutions | 0.79577005 |
| Implied Shares Outstanding | 41,778,687 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut. |
| Market | us_market |
| Market Cap | 4,013,678,592 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_684321879 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -98,802,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,943,908,052 |
| Number Of Analyst Opinions | 4 |
| Open | 94.37 |
| Operating Cashflow | -79,453,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | (228) 372-3376 |
| Post Market Change | -2.0697021 |
| Post Market Change Percent | -2.1543689 |
| Post Market Price | 94.0003 |
| Post Market Time | 1,781,305,123 |
| Previous Close | 94.4 |
| Price Eps Current Year | -31.501976 |
| Price Hint | 2 |
| Price To Book | 9.182756 |
| Profit Margins | 0.0 |
| Quick Ratio | 58.435 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Region | US |
| Regular Market Change | 1.67 |
| Regular Market Change Percent | 1.76907 |
| Regular Market Day High | 98.93 |
| Regular Market Day Low | 92.11 |
| Regular Market Day Range | 92.11 - 98.93 |
| Regular Market Open | 94.37 |
| Regular Market Previous Close | 94.4 |
| Regular Market Price | 96.07 |
| Regular Market Time | 1,781,294,403 |
| Regular Market Volume | 245,863 |
| Sand P52 Week Change | 0.23177934 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 41,778,687 |
| Shares Percent Shares Out | 0.056599997 |
| Shares Short | 2,363,440 |
| Shares Short Previous Month Date | 1,777,507,200 |
| Shares Short Prior Month | 2,059,233 |
| Short Name | Veradermics, Incorporated |
| Short Percent Of Float | 0.086899996 |
| Short Ratio | 3.76 |
| Source Interval | 15 |
| State | CT |
| Symbol | MANE |
| Target High Price | 138.0 |
| Target Low Price | 120.0 |
| Target Mean Price | 132.25 |
| Target Median Price | 135.5 |
| Total Cash | 390,796,992 |
| Total Cash Per Share | 9.354 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.64 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 73.17389 |
| Two Hundred Day Average Change | 22.89611 |
| Two Hundred Day Average Change Percent | 0.3129 |
| Type Disp | Equity |
| Volume | 245,863 |
| Website | https://www.veradermics.com |
| Zip | 6,513 |